Entyvio 300 mg prašek za koncentrat za raztopino za infundiranje
Vedolizumab
Composition and organoleptic properties
| Name | Role | Strength | Strength expression |
|---|---|---|---|
| vedolizumab | — | 300 mg/1 prašek | — |
Organoleptic description—
Drug status
The medicinal product is present in wholesale distribution.
Last drug update date:9. 7. 2026